Xenon Xe 133

   
Google
 
Web NewDrugInformation.com

Xenon Xe 133


Drug - Xenon Xe 133
The trade name of the product as shown on the labeling.

Dosage - GAS; INHALATION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Xenon, Xe-133
Multiple ingredients are in alphabetical order.

Strength - 20mCi/VIAL
The potency of the active ingredient(s), Xenon, Xe-133. May repeat for multiple part products.

Applicant - MALLINCKRODT
The firm name holding legal responsibility for Xenon Xe 133. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018327
The FDA assigned number to Xenon Xe 133. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Xenon Xe 133. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AA
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 9, 1982
The date Xenon Xe 133 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Xenon Xe 133. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Xenon Xe 133 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mallinckrodt Medical Inc
The full name of the firm holding legal responsibility for the new application of Xenon Xe 133.

Xenon Xe 133